ENTA Enanta Pharmaceuticals, Inc.
Healthcare$13.95+0.87%ClosedMarket Cap: $323.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$48.20
Target (Median)
$54.00
Target Range
$20.00 - $87.00
Upside from current price: 245.5%
Rating Distribution
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-01 | Jefferies | upgrade | Buy | Hold |
| 2025-09-30 | WestPark Capital | maintain | Buy | Buy |
| 2025-09-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2025-08-12 | JMP Securities | maintain | Market Outperform | Market Outperform |
| 2025-06-03 | JMP Securities | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-1.75 | $65.2M | 5 |
| Sat Sep 30 | $-2.18 | $67.5M | 4 |
| Sun Sep 30 | $-2.33 | $71.4M | 1 |
| Mon Sep 30 | $-2.68 | $104.0M | 1 |